Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HC.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FE.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.15.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.4.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.8.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDRENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.43.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.7.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KV.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.1.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JC.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDPENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCKENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GN.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GY.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HH.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.13.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.7.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.7.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JP.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used